Mohamed Rahouma, MD

Surgical Oncology Department, National Cancer Institute (NCI), Cairo University, Egypt
Department of Cardiothoracic Surgery, Weill Cornell Medicine (WCM) / New York Presbyterian Hospital, New York, USA

Dr. Rahouma is currently Research Associate in Department of Cardiothoracic Surgery, Weill Cornell Medicine/New York Presbyterian Hospital, New York, USA and Assistant Lecturer in Surgical Oncology Department, NCI, Cairo University, Egypt.

He is especially dedicated to thoracic surgical oncology in addition to his gained experience in minimally invasive cardiothoracic surgery. He got a deep working experience in statistics and meta-analysis in particular and successfully published over 25 meta-analyses till now working from his both affiliations (NCI/Egypt and Cornell/USA).

He received his medical degree from Cairo University in 2007, finished his surgical oncology residency in 2012 and earned Master in Surgical Oncology (MSc) in 2013 from NCI/Cairo University in addition to membership of Intercollegiate Royal College of Surgeons (Intercollegiate MRCS) in 2013. He promoted to Assistant Lecturer and joined faculty staff of NCI/Cairo University in 2013 and he finished 2 years of fellowship in surgical oncology with particular emphasis on thoracic malignancies. Since 2015, he is working as a research fellow on his clinical PhD in minimally invasive esophageal cancer in a joint supervision mission between NCI/Egypt and Cornell/USA. At 2018, he was promoted from research fellow to be research associate in Cardiothoracic Surgery, WCM.

Dr Rahouma researches focus on investigation of the best treatment modalities for thoracic cancer patients that included but not limited to lung, esophageal cancer, thymoma, mesothelioma, hyperthermic intra-pleural/intra-peritoneal chemotherapy and immunotherapy in addition to his work on cardiac surgery and meta-analysis as well.

He has published almost 150 articles, and be an editor in 5 journals and reviewers in 7 journals with particular interest in Minimally Invasive Cardiothoracic Surgery (including tumors of lung, thymus, esophagus in addition to minimally invasive coronary artery bypass graft and mitral surgery). He is also interested in conducting meta-analyses in different Cardiothoracic Surgery and Oncology fields. Currently he is editing a book about Thoracic Malignancies: A Deep Insight in addition to many ongoing meta-analyses and meta-analysis of prior meta-analyses.

Articles Published in the Journal of Thoracic Disease
    - Pneumonitis as a complication of immune system targeting drugs? A meta-analysis of anti-PD/PD-L1 immunotherapy randomized clinical trials
    - Contributing factors to the outcome of primary malignant chest wall tumors